The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma M Ehtesham, P Kabos, A Kabosova, T Neuman, KL Black, JS Yu Cancer research 62 (20), 5657-5663, 2002 | 459 | 2002 |
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand M Ehtesham, P Kabos, MAR Gutierrez, NHC Chung, TS Griffith, KL Black, ... Cancer research 62 (24), 7170-7174, 2002 | 393 | 2002 |
CXCR4 expression mediates glioma cell invasiveness M Ehtesham, JA Winston, P Kabos, RC Thompson Oncogene 25 (19), 2801-2806, 2006 | 237 | 2006 |
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma Y Akasaki, G Liu, NHC Chung, M Ehtesham, KL Black, JS Yu The Journal of Immunology 173 (7), 4352-4359, 2004 | 225 | 2004 |
Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4 M Ehtesham, X Yuan, P Kabos, NHC Chung, G Liu, Y Akasaki, KL Black, ... Neoplasia 6 (3), 287-293, 2004 | 201 | 2004 |
Generation of neural progenitor cells from whole adult bone marrow P Kabos, M Ehtesham, A Kabosova, KL Black, SY John Experimental neurology 178 (2), 288-293, 2002 | 197 | 2002 |
Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging TK Sinha, S Khatib-Shahidi, TE Yankeelov, K Mapara, M Ehtesham, ... Nature methods 5 (1), 57-59, 2008 | 184 | 2008 |
CXCR4 mediates the proliferation of glioblastoma progenitor cells M Ehtesham, KY Mapara, CB Stevenson, RC Thompson Cancer letters 274 (2), 305-312, 2009 | 179 | 2009 |
Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells M Ehtesham, A Sarangi, JG Valadez, S Chanthaphaychith, MW Becher, ... Oncogene 26 (39), 5752-5761, 2007 | 177 | 2007 |
Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival X Bian, S Yang, J Chen, Y Ping, X Zhou, Q Wang, X Jiang, W Gong, ... Neurosurgery 61 (3), 570-579, 2007 | 154* | 2007 |
In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma Y Liu, M Ehtesham, K Samoto, CJ Wheeler, RC Thompson, LP Villarreal, ... Cancer gene therapy 9 (1), 9-15, 2002 | 115 | 2002 |
Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer M Ehtesham, K Samoto, P Kabos, FL Acosta, MAR Gutierrez, KL Black, ... Cancer gene therapy 9 (11), 925-934, 2002 | 97 | 2002 |
Small interference RNA modulation of IL‐10 in human monocyte‐derived dendritic cells enhances the Th1 response G Liu, H Ng, Y Akasaki, X Yuan, M Ehtesham, D Yin, KL Black, JS Yu European journal of immunology 34 (6), 1680-1687, 2004 | 94 | 2004 |
Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats M Ehtesham, P Kabos, MAR Gutierrez, K Samoto, KL Black, SY John Journal of immunotherapy 26 (2), 107-116, 2003 | 88 | 2003 |
CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal … CB Stevenson, M Ehtesham, KM McMillan, JG Valadez, ML Edgeworth, ... Neurosurgery 63 (3), 560-570, 2008 | 86 | 2008 |
Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium JS Yu, PK Lee, M Ehtesham, K Samoto, KL Black, CJ Wheeler Journal of neuro-oncology 64, 55-61, 2003 | 77 | 2003 |
Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials M Ehtesham, KL Black, JS Yu Cancer control 11 (3), 192-207, 2004 | 72 | 2004 |
Differentiation of whole bone marrow SY John, P Kabos, M Ehtesham US Patent 7,129,034, 2006 | 68 | 2006 |
Stem cell therapies for malignant glioma M Ehtesham, CB Stevenson, RC Thompson Neurosurgical Focus 19 (3), 1-11, 2005 | 62 | 2005 |
The role of the CXCR4 cell surface chemokine receptor in glioma biology M Ehtesham, E Min, NM Issar, RA Kasl, IS Khan, RC Thompson Journal of neuro-oncology 113, 153-162, 2013 | 44 | 2013 |